Logo image of JEN.BR

JENSEN-GROUP NV (JEN.BR) Stock Fundamental Analysis

EBR:JEN - Euronext Brussels - BE0003858751 - Common Stock - Currency: EUR

56.4  -0.8 (-1.4%)

Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to JEN. JEN was compared to 102 industry peers in the Machinery industry. While JEN belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. JEN is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

JEN had positive earnings in the past year.
In the past year JEN had a positive cash flow from operations.
JEN had positive earnings in each of the past 5 years.
JEN had a positive operating cash flow in 4 of the past 5 years.
JEN.BR Yearly Net Income VS EBIT VS OCF VS FCFJEN.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M

1.2 Ratios

The Return On Assets of JEN (7.97%) is better than 88.24% of its industry peers.
JEN's Return On Equity of 14.57% is amongst the best of the industry. JEN outperforms 84.31% of its industry peers.
Looking at the Return On Invested Capital, with a value of 11.74%, JEN belongs to the top of the industry, outperforming 88.24% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for JEN is in line with the industry average of 8.63%.
The 3 year average ROIC (9.39%) for JEN is below the current ROIC(11.74%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 7.97%
ROE 14.57%
ROIC 11.74%
ROA(3y)6.55%
ROA(5y)5.36%
ROE(3y)12.05%
ROE(5y)10.23%
ROIC(3y)9.39%
ROIC(5y)8.21%
JEN.BR Yearly ROA, ROE, ROICJEN.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

JEN has a better Profit Margin (9.08%) than 83.33% of its industry peers.
In the last couple of years the Profit Margin of JEN has grown nicely.
The Operating Margin of JEN (11.20%) is better than 79.41% of its industry peers.
JEN's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 13.64%, JEN is doing worse than 90.20% of the companies in the same industry.
In the last couple of years the Gross Margin of JEN has grown nicely.
Industry RankSector Rank
OM 11.2%
PM (TTM) 9.08%
GM 13.64%
OM growth 3Y8.87%
OM growth 5Y10.05%
PM growth 3Y17.42%
PM growth 5Y13.94%
GM growth 3Y8.28%
GM growth 5Y10.4%
JEN.BR Yearly Profit, Operating, Gross MarginsJEN.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

6

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), JEN is creating some value.
Compared to 1 year ago, JEN has less shares outstanding
The number of shares outstanding for JEN has been increased compared to 5 years ago.
JEN has a worse debt/assets ratio than last year.
JEN.BR Yearly Shares OutstandingJEN.BR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
JEN.BR Yearly Total Debt VS Total AssetsJEN.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

2.2 Solvency

An Altman-Z score of 3.43 indicates that JEN is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.43, JEN is in the better half of the industry, outperforming 79.41% of the companies in the same industry.
JEN has a debt to FCF ratio of 3.68. This is a good value and a sign of high solvency as JEN would need 3.68 years to pay back of all of its debts.
With a decent Debt to FCF ratio value of 3.68, JEN is doing good in the industry, outperforming 67.65% of the companies in the same industry.
A Debt/Equity ratio of 0.08 indicates that JEN is not too dependend on debt financing.
JEN has a better Debt to Equity ratio (0.08) than 84.31% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF 3.68
Altman-Z 3.43
ROIC/WACC1.63
WACC7.21%
JEN.BR Yearly LT Debt VS Equity VS FCFJEN.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M

2.3 Liquidity

JEN has a Current Ratio of 1.73. This is a normal value and indicates that JEN is financially healthy and should not expect problems in meeting its short term obligations.
JEN has a Current ratio of 1.73. This is comparable to the rest of the industry: JEN outperforms 57.84% of its industry peers.
JEN has a Quick Ratio of 1.35. This is a normal value and indicates that JEN is financially healthy and should not expect problems in meeting its short term obligations.
JEN has a better Quick ratio (1.35) than 73.53% of its industry peers.
Industry RankSector Rank
Current Ratio 1.73
Quick Ratio 1.35
JEN.BR Yearly Current Assets VS Current LiabilitesJEN.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

4

3. Growth

3.1 Past

JEN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 26.20%, which is quite impressive.
JEN shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 16.40% yearly.
The Revenue has grown by 13.26% in the past year. This is quite good.
The Revenue has been growing slightly by 6.41% on average over the past years.
EPS 1Y (TTM)26.2%
EPS 3Y32.2%
EPS 5Y16.4%
EPS Q2Q%37.94%
Revenue 1Y (TTM)13.26%
Revenue growth 3Y20.39%
Revenue growth 5Y6.41%
Sales Q2Q%16.76%

3.2 Future

JEN is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 5.01% yearly.
The Revenue is expected to grow by 3.68% on average over the next years.
EPS Next Y6.19%
EPS Next 2Y5.39%
EPS Next 3Y4.65%
EPS Next 5Y5.01%
Revenue Next Year12.93%
Revenue Next 2Y8.38%
Revenue Next 3Y6.45%
Revenue Next 5Y3.68%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
JEN.BR Yearly Revenue VS EstimatesJEN.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 100M 200M 300M 400M 500M
JEN.BR Yearly EPS VS EstimatesJEN.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1 2 3 4 5

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 13.03, which indicates a correct valuation of JEN.
Compared to the rest of the industry, the Price/Earnings ratio of JEN indicates a somewhat cheap valuation: JEN is cheaper than 75.49% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of JEN to the average of the S&P500 Index (27.93), we can say JEN is valued rather cheaply.
A Price/Forward Earnings ratio of 11.63 indicates a reasonable valuation of JEN.
Based on the Price/Forward Earnings ratio, JEN is valued a bit cheaper than 63.73% of the companies in the same industry.
JEN is valuated cheaply when we compare the Price/Forward Earnings ratio to 37.78, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 13.03
Fwd PE 11.63
JEN.BR Price Earnings VS Forward Price EarningsJEN.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

JEN's Enterprise Value to EBITDA ratio is in line with the industry average.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of JEN is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 28.8
EV/EBITDA 9.29
JEN.BR Per share dataJEN.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates JEN does not grow enough to justify the current Price/Earnings ratio.
JEN has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)2.1
PEG (5Y)0.79
EPS Next 2Y5.39%
EPS Next 3Y4.65%

3

5. Dividend

5.1 Amount

JEN has a Yearly Dividend Yield of 1.21%. Purely for dividend investing, there may be better candidates out there.
JEN's Dividend Yield is comparable with the industry average which is at 2.85.
Compared to an average S&P500 Dividend Yield of 2.32, JEN's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 1.21%

5.2 History

The dividend of JEN decreases each year by -5.10%.
Dividend Growth(5Y)-5.1%
Div Incr Years2
Div Non Decr Years4
JEN.BR Yearly Dividends per shareJEN.BR Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

JEN pays out 17.86% of its income as dividend. This is a sustainable payout ratio.
DP17.86%
EPS Next 2Y5.39%
EPS Next 3Y4.65%
JEN.BR Yearly Income VS Free CF VS DividendJEN.BR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M
JEN.BR Dividend Payout.JEN.BR Dividend Payout, showing the Payout Ratio.JEN.BR Dividend Payout.PayoutRetained Earnings

JENSEN-GROUP NV

EBR:JEN (7/29/2025, 4:59:06 PM)

56.4

-0.8 (-1.4%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)05-19 2025-05-19
Earnings (Next)08-07 2025-08-07
Inst Owners9.15%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap543.13M
Analysts80
Price Target54.57 (-3.24%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.21%
Yearly Dividend0.77
Dividend Growth(5Y)-5.1%
DP17.86%
Div Incr Years2
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)122.92%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 13.03
Fwd PE 11.63
P/S 1.2
P/FCF 28.8
P/OCF 17.74
P/B 1.92
P/tB 2.36
EV/EBITDA 9.29
EPS(TTM)4.33
EY7.68%
EPS(NY)4.85
Fwd EY8.6%
FCF(TTM)1.96
FCFY3.47%
OCF(TTM)3.18
OCFY5.64%
SpS47.06
BVpS29.35
TBVpS23.91
PEG (NY)2.1
PEG (5Y)0.79
Profitability
Industry RankSector Rank
ROA 7.97%
ROE 14.57%
ROCE 15.62%
ROIC 11.74%
ROICexc 14.09%
ROICexgc 17.48%
OM 11.2%
PM (TTM) 9.08%
GM 13.64%
FCFM 4.16%
ROA(3y)6.55%
ROA(5y)5.36%
ROE(3y)12.05%
ROE(5y)10.23%
ROIC(3y)9.39%
ROIC(5y)8.21%
ROICexc(3y)11.13%
ROICexc(5y)10.46%
ROICexgc(3y)12.99%
ROICexgc(5y)12.14%
ROCE(3y)13.16%
ROCE(5y)11.32%
ROICexcg growth 3Y5.22%
ROICexcg growth 5Y2.88%
ROICexc growth 3Y5.28%
ROICexc growth 5Y0.03%
OM growth 3Y8.87%
OM growth 5Y10.05%
PM growth 3Y17.42%
PM growth 5Y13.94%
GM growth 3Y8.28%
GM growth 5Y10.4%
F-Score6
Asset Turnover0.88
Health
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF 3.68
Debt/EBITDA 0.37
Cap/Depr 132.29%
Cap/Sales 2.59%
Interest Coverage 28.09
Cash Conversion 51.35%
Profit Quality 45.81%
Current Ratio 1.73
Quick Ratio 1.35
Altman-Z 3.43
F-Score6
WACC7.21%
ROIC/WACC1.63
Cap/Depr(3y)117.95%
Cap/Depr(5y)108.4%
Cap/Sales(3y)2.08%
Cap/Sales(5y)2.24%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)26.2%
EPS 3Y32.2%
EPS 5Y16.4%
EPS Q2Q%37.94%
EPS Next Y6.19%
EPS Next 2Y5.39%
EPS Next 3Y4.65%
EPS Next 5Y5.01%
Revenue 1Y (TTM)13.26%
Revenue growth 3Y20.39%
Revenue growth 5Y6.41%
Sales Q2Q%16.76%
Revenue Next Year12.93%
Revenue Next 2Y8.38%
Revenue Next 3Y6.45%
Revenue Next 5Y3.68%
EBIT growth 1Y24.53%
EBIT growth 3Y31.06%
EBIT growth 5Y17.1%
EBIT Next Year51.02%
EBIT Next 3Y17.26%
EBIT Next 5Y12.63%
FCF growth 1Y39.35%
FCF growth 3Y-6.22%
FCF growth 5Y1.6%
OCF growth 1Y41.62%
OCF growth 3Y-2.15%
OCF growth 5Y3.17%